A novel liposome-encapsulated hemoglobin/silica nanoparticle as an oxygen carrier

Int J Pharm. 2012 May 10;427(2):354-7. doi: 10.1016/j.ijpharm.2012.02.019. Epub 2012 Feb 18.

Abstract

A novel liposome-encapsulated hemoglobin/silica nanoparticle (LEHSN) was fabricated by a water-in-oil-in-water (W/O/W) double emulsion approach. Bovine hemoglobin (Hb) was first adsorbed onto the surfaces of silica nanoparticles (SNs), and then the complex of Hb/SNs was encapsulated by liposome to form LEHSN which has a core-shell supramolecular structure. On the one hand, liposomes built a cell membrane-like environment for the controlled release of Hb. On the other hand, SNs which act as rigid core provide a supported framework for lecithin membrane, and enhance the stability of liposomes. In comparison with liposome-encapsulated Hb (LEH), LEHSN shows substantially enhanced stability and improved release property of Hb in vitro. This study highlights the potential of the novel LEHSN as an oxygen carrier for pharmaceutical applications.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adsorption
  • Animals
  • Blood Substitutes / administration & dosage*
  • Blood Substitutes / pharmacokinetics
  • Cattle
  • Colloids
  • Delayed-Action Preparations
  • Drug Compounding
  • Drug Stability
  • Emulsions
  • Hemoglobins / administration & dosage*
  • Hemoglobins / pharmacokinetics
  • Lecithins / chemistry
  • Liposomes
  • Membranes, Artificial
  • Microscopy, Electron, Transmission
  • Nanoparticles
  • Oxygen / administration & dosage*
  • Particle Size
  • Silicon Dioxide
  • Spectroscopy, Fourier Transform Infrared

Substances

  • Blood Substitutes
  • Colloids
  • Delayed-Action Preparations
  • Emulsions
  • Hemoglobins
  • Lecithins
  • Liposomes
  • Membranes, Artificial
  • Silicon Dioxide
  • Oxygen